|
MechanismIL-12R modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Libo Pharma Corp.
0 Patents (Medical) associated with Libo Pharma Corp.
100 Deals associated with Libo Pharma Corp.
100 Translational Medicine associated with Libo Pharma Corp.